Abeona Therapeutics (ABEO) Total Current Liabilities (2010 - 2026)
Abeona Therapeutics (ABEO) posted quarterly Total Current Liabilities of $31.0 million for Q1 2026, up 72.64% year-over-year from $18.0 million in Q1 2025, and up 4.99% quarter-over-quarter from $29.6 million in Q4 2025.
Abeona Therapeutics (ABEO) Total Current Liabilities (2010 - 2026) Analysis & Trends
Abeona Therapeutics' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $31.0 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 72.64% year-over-year to $31.0 million; the TTM figure through Mar 2026 stood at $31.0 million (up 72.64% YoY), while the FY2025 annual figure was $29.6 million, up 78.27% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $31.0 million, up from $29.6 million in the prior quarter.
- The five-year high for Total Current Liabilities was $34.5 million in Q2 2025, with the low at $7.4 million in Q1 2023.
- The 5-year median for Total Current Liabilities is $13.7 million (2022), against an average of $16.7 million.
- The sharpest annual moves came in 2022 and 2024: Total Current Liabilities sank 69.79% in 2022, then soared 119.0% in 2024.
- Abeona Therapeutics' Total Current Liabilities stood at $7.8 million in 2022, then soared by 72.54% to $13.4 million in 2023, then grew by 23.58% to $16.6 million in 2024, then jumped by 78.27% to $29.6 million in 2025, then climbed by 4.99% to $31.0 million in 2026.
- Business Quant data shows ABEO's Total Current Liabilities at $31.0 million in Q1 2026, $29.6 million in Q4 2025, and $22.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Abeona Therapeutics | 342.78 Mn | 195.96 Mn | 7.20 Mn | 24.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.81 Mn |
| Mar 31, 2026 | 31.05 Mn |
| Dec 31, 2025 | 29.57 Mn |
| Sep 30, 2025 | 22.18 Mn |
| Jun 30, 2025 | 34.52 Mn |
| Mar 31, 2025 | 17.98 Mn |
| Dec 31, 2024 | 16.59 Mn |
| Sep 30, 2024 | 18.42 Mn |
| Jun 30, 2024 | 16.84 Mn |
| Mar 31, 2024 | 11.89 Mn |
| Dec 31, 2023 | 13.42 Mn |
| Sep 30, 2023 | 8.41 Mn |
| Jun 30, 2023 | 9.44 Mn |
| Mar 31, 2023 | 7.42 Mn |
| Dec 31, 2022 | 7.78 Mn |
| Sep 30, 2022 | 12.60 Mn |
| Jun 30, 2022 | 13.69 Mn |
| Mar 31, 2022 | 12.34 Mn |
| Dec 31, 2021 | 16.62 Mn |
| Sep 30, 2021 | 26.47 Mn |